(HAIN) The Hain Celestial - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4052171000

Infant Formula, Plant-Based Beverages, Organic Snacks, Herbal Tea, Personal Care

Stock: Packaged Foods & Meats
Age 32.2y

MCap 110m
Avg Vol 1.34M (1.52M USD)

Beta 0.557
Volatility 85.37%

EPS (Earnings per Share)

EPS CAGR: -34.00%
EPS Trend: -67.0%

Last SUE: 0.12
Qual. Beats: 0

Revenue

Rev. CAGR: -6.69%
Rev. Trend: -91.8%

Last SUE: 0.72
Qual. Beats: 0

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	85.4%
Value at Risk 5%th	124%
Relative Tail Risk	-12.05%

Reward TTM
Sharpe Ratio	-1.09
Alpha	-83.91
CAGR/Max DD	-0.63

Character TTM
Hurst Exponent	0.314
Beta	0.557
Beta Downside	0.469

Drawdowns 3y
Max DD	95.41%
Mean DD	64.96%
Median DD	65.67%

Description: HAIN The Hain Celestial January 17, 2026

The Hain Celestial Group (NASDAQ: HAIN) is a diversified producer of organic and natural consumer goods, ranging from infant nutrition and plant-based beverages to personal-care items. Its portfolio includes well-known brands such as Alba Botanica, Avalon Organics, Earth’s Best, JASON, Celestial Seasonings, Spectrum, and MaraNatha, covering categories from baby foods and snack chips to herbal teas and skin-care products.

Its products are sold across a broad channel mix-specialty natural-food distributors, mainstream supermarkets, mass-market and e-commerce retailers, food-service operators, and drug-store chains-in the United States, United Kingdom, Europe, and other international markets. This multi-channel reach helps mitigate reliance on any single retail partner.

Key operating metrics (FY 2023) show revenue of roughly $1.5 billion, a year-over-year increase of about 5%, and an adjusted gross margin near 38%. The company’s organic sales grew 4% in Q4 2023, outpacing the broader packaged-foods index, which is driven by a sustained consumer shift toward clean-label products and a projected 8% CAGR for the global natural-and-organic foods market through 2029. Inflationary pressure on discretionary spending remains a headwind, but Hain’s price-elastic, health-focused product mix tends to be more resilient than conventional snack categories.

For a deeper quantitative breakdown, the ValueRay platform offers a concise, data-driven view of HAIN’s valuation drivers and risk factors.

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income: -279.8m TTM > 0 and > 6% of Revenue
FCF/TA: -0.00 > 0.02 and ΔFCF/TA -3.10 > 1.0
NWC/Revenue: 16.01% < 20% (prev 16.61%; Δ -0.60% < -1%)
CFO/TA 0.01 > 3% & CFO 18.6m > Net Income -279.8m
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 1.89 > 1.5 & < 3
Outstanding Shares: last quarter (90.3m) vs 12m ago 0.54% < -2%
Gross Margin: 20.44% > 18% (prev 0.22%; Δ 2022 % > 0.5%)
Asset Turnover: 82.72% > 50% (prev 79.91%; Δ 2.81% > 0%)
Interest Coverage Ratio: -4.01 > 6 (EBITDA TTM -179.4m / Interest Expense TTM 53.9m)

Altman Z'' 0.32

A: 0.16 (Total Current Assets 523.0m - Total Current Liabilities 276.8m) / Total Assets 1.58b
B: 0.02 (Retained Earnings 26.1m / Total Assets 1.58b)
C: -0.12 (EBIT TTM -216.3m / Avg Total Assets 1.86b)
D: 0.02 (Book Value of Equity 26.1m / Total Liabilities 1.14b)
Altman-Z'' Score: 0.32 = B

Beneish M -3.32

DSRI: 1.01 (Receivables 170.7m/188.2m, Revenue 1.54b/1.71b)
GMI: 1.09 (GM 20.44% / 22.19%)
AQI: 0.81 (AQ_t 0.46 / AQ_t-1 0.57)
SGI: 0.90 (Revenue 1.54b / 1.71b)
TATA: -0.19 (NI -279.8m - CFO 18.6m) / TA 1.58b)
Beneish M-Score: -3.32 (Cap -4..+1) = AA

ValueRay F-Score (Strict, 0-100) 23.96

1. Piotroski: 3.50pt
2. FCF Yield: -0.61%
3. FCF Margin: -0.34%
4. Debt/Equity: 1.75
5. Debt/Ebitda: data missing
6. ROIC - WACC: -15.32%
7. RoE: -46.80%
8. Revenue Trend: -91.85%
9. EPS Trend: -67.04%

What is the price of HAIN shares?

As of January 26, 2026, the stock is trading at USD 1.26 with a total of 1,094,369 shares traded.
Over the past week, the price has changed by +7.69%, over one month by +8.62%, over three months by -10.00% and over the past year by -76.80%.

Is HAIN a buy, sell or hold?

The Hain Celestial has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold HAIN.

Strong Buy: 2
Buy: 1
Hold: 7
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the HAIN price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	2.4	91.3%
Analysts Target Price	2.4	91.3%
ValueRay Target Price	0.5	-61.9%

HAIN Fundamental Data Overview January 19, 2026

P/E Forward = 17.8891
P/S = 0.0721
P/B = 0.2483
P/EG = 0.8449
Revenue TTM = 1.54b USD
EBIT TTM = -216.3m USD
EBITDA TTM = -179.4m USD
Long Term Debt = 708.0m USD (from longTermDebt, last quarter)
Short Term Debt = 7.50m USD (from shortLongTermDebt, last quarter)
Debt = 779.2m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 667.6m USD (from netDebt column, last quarter)
Enterprise Value = 841.8m USD (110.5m + Debt 779.2m - CCE 47.9m)
Interest Coverage Ratio = -4.01 (Ebit TTM -216.3m / Interest Expense TTM 53.9m)
EV/FCF = -162.9x (Enterprise Value 841.8m / FCF TTM -5.17m)
FCF Yield = -0.61% (FCF TTM -5.17m / Enterprise Value 841.8m)
FCF Margin = -0.34% (FCF TTM -5.17m / Revenue TTM 1.54b)
Net Margin = -18.20% (Net Income TTM -279.8m / Revenue TTM 1.54b)
Gross Margin = 20.44% ((Revenue TTM 1.54b - Cost of Revenue TTM 1.22b) / Revenue TTM)
Gross Margin QoQ = 18.51% (prev 18.51%)
Tobins Q-Ratio = 0.53 (Enterprise Value 841.8m / Total Assets 1.58b)
Interest Expense / Debt = 1.99% (Interest Expense 15.5m / Debt 779.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = -170.9m (EBIT -216.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.89 (Total Current Assets 523.0m / Total Current Liabilities 276.8m)
Debt / Equity = 1.75 (Debt 779.2m / totalStockholderEquity, last quarter 445.0m)
Debt / EBITDA = -3.72 (negative EBITDA) (Net Debt 667.6m / EBITDA -179.4m)
Debt / FCF = -129.2 (out of range, set to none) (Net Debt 667.6m / FCF TTM -5.17m)
Total Stockholder Equity = 597.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -15.05% (Net Income -279.8m / Total Assets 1.58b)
RoE = -46.80% (Net Income TTM -279.8m / Total Stockholder Equity 597.9m)
RoCE = -16.57% (EBIT -216.3m / Capital Employed (Equity 597.9m + L.T.Debt 708.0m))
RoIC = -12.95% (negative operating profit) (NOPAT -170.9m / Invested Capital 1.32b)
WACC = 2.37% (E(110.5m)/V(889.7m) * Re(7.97%) + D(779.2m)/V(889.7m) * Rd(1.99%) * (1-Tc(0.21)))
Discount Rate = 7.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.30%
Fair Price DCF = unknown (Cash Flow -5.17m)
EPS Correlation: -67.04 | EPS CAGR: -34.00% | SUE: 0.12 | # QB: 0
Revenue Correlation: -91.85 | Revenue CAGR: -6.69% | SUE: 0.72 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.07 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=4
EPS current Year (2026-06-30): EPS=0.02 | Chg30d=-0.082 | Revisions Net=+0 | Growth EPS=-81.5% | Growth Revenue=-4.3%
EPS next Year (2027-06-30): EPS=0.20 | Chg30d=-0.017 | Revisions Net=+0 | Growth EPS=+1075.8% | Growth Revenue=+1.2%

Additional Sources for HAIN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle